α-Actinin-4 promotes the progression of castration-resistant prostate cancer.

被引:0
|
作者
Park, S. [1 ]
Ko, J. [1 ]
机构
[1] Korea Univ, Life Sci, Seoul, South Korea
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P2100
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Aryl hydrocarbon receptor activity promotes cancer progression and drug resistance in castration-resistant prostate cancer cells
    Khamit-Kush, Kofi K.
    Bowen, Nathan J.
    Handy, Jeffrey A.
    Powell, Joann B.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [32] Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone
    Fradet, Anais
    Bouchet, Mathilde
    Delliaux, Carine
    Gervais, Manon
    Kan, Casina
    Benetollo, Claire
    Pantano, Francesco
    Vargas, Geoffrey
    Bouazza, Lamia
    Croset, Martine
    Bala, Yohann
    Leroy, Xavier
    Rosol, Thomas J.
    Rieusset, Jennifer
    Bellahcene, Akeila
    Castronovo, Vincent
    Aubin, Jane E.
    Clezardin, Philippe
    Duterque-Coquillaud, Martine
    Bonnelye, Edith
    ONCOTARGET, 2016, 7 (47) : 77071 - 77086
  • [33] Early PSA progression in abiraterone/enzalutamide-treated patients with metastatic castration-resistant prostate cancer.
    Lopez-Campos, Fernando
    Gomez-Iturriaga, Alfonso
    Llacer Perez, Casilda
    Henriquez, Ivan
    Peleteiro, Paula
    Lozano, Rebeca
    Castano, Ana
    Romero-Laorden, Nuria
    Molina-Cerrillo, Javier
    Alvarez-Rodriguez, Sara
    Piquer, Teresa
    Navarro-Castellon, Joaquin
    Jose Conde-Moreno, Antonio
    Ramirez-Backhaus, Miguel
    Barrionuevo, Patricia
    Garcia, Raquel
    de los Llanos Perez-Haro, Maria
    Castro, Elena
    Olmos, David
    Lorente, David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Targeting fibroblast growth factor receptors in castration-resistant prostate cancer.
    Labrecque, Mark P.
    Brown, Lisha G.
    Coleman, Ilsa M.
    Lakely, Bryce
    Nguyen, Holly M.
    Corey, Eva
    Nelson, Peter S.
    Morrissey, Colm
    CANCER RESEARCH, 2021, 81 (13)
  • [35] Lipidomic profiling in patients with heavily pretreated castration-resistant prostate cancer.
    Cattrini, Carlo
    Manfredi, Marcello
    Barboro, Paola
    Ghirimoldi, Marco
    Mennitto, Alessia
    Martini, Veronica
    Biello, Federica
    D'Avanzo, Francesca
    Platini, Francesca
    Maggiora, Paola Maria
    Branni, Carmen
    Rua, Alessia
    Diprima, Santo
    Tassone, Andrea
    Gobbato, Simone
    Stella, Arianna
    Zanardi, Elisa
    Pinato, David James
    Boccardo, Francesco
    Gennari, Alessandra
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [36] Circulating miRNA signatures: a new challenge in castration-resistant prostate cancer.
    Noto, Laura
    Picciotto, Maria
    Curro, Monica
    Franchina, Tindara
    Chiofalo, Giuseppe
    Del Re, Cristina
    Caccamo, Daniela
    Ientile, Riccardo
    Adamo, Vincenzo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Palliative systemic therapy of castration-resistant prostate cancer. Current developments
    Finter, F.
    Rinnab, L.
    Gust, K.
    Kuefer, R.
    UROLOGE, 2009, 48 (11): : 1295 - 1301
  • [38] IL-23 promotes the development of castration-resistant prostate cancer
    Yan, Juming
    Cua, Daniel J.
    Teng, Michele W. L.
    IMMUNOLOGY AND CELL BIOLOGY, 2018, 96 (09): : 883 - 885
  • [39] Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer
    Akash K. Kaushik
    Ali Shojaie
    Katrin Panzitt
    Rajni Sonavane
    Harene Venghatakrishnan
    Mohan Manikkam
    Alexander Zaslavsky
    Vasanta Putluri
    Vihas T. Vasu
    Yiqing Zhang
    Ayesha S. Khan
    Stacy Lloyd
    Adam T. Szafran
    Subhamoy Dasgupta
    David A. Bader
    Fabio Stossi
    Hangwen Li
    Susmita Samanta
    Xuhong Cao
    Efrosini Tsouko
    Shixia Huang
    Daniel E. Frigo
    Lawrence Chan
    Dean P. Edwards
    Benny A. Kaipparettu
    Nicholas Mitsiades
    Nancy L. Weigel
    Michael Mancini
    Sean E. McGuire
    Rohit Mehra
    Michael M. Ittmann
    Arul M. Chinnaiyan
    Nagireddy Putluri
    Ganesh S. Palapattu
    George Michailidis
    Arun Sreekumar
    Nature Communications, 7
  • [40] Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer
    Kaushik, Akash K.
    Shojaie, Ali
    Panzitt, Katrin
    Sonavane, Rajni
    Venghatakrishnan, Harene
    Manikkam, Mohan
    Zaslavsky, Alexander
    Putluri, Vasanta
    Vasu, Vihas T.
    Zhang, Yiqing
    Khan, Ayesha S.
    Lloyd, Stacy
    Szafran, Adam T.
    Dasgupta, Subhamoy
    Bader, David A.
    Stossi, Fabio
    Li, Hangwen
    Samanta, Susmita
    Cao, Xuhong
    Tsouko, Efrosini
    Huang, Shixia
    Frigo, Daniel E.
    Chan, Lawrence
    Edwards, Dean P.
    Kaipparettu, Benny A.
    Mitsiades, Nicholas
    Weigel, Nancy L.
    Mancini, Michael
    McGuire, Sean E.
    Mehra, Rohit
    Ittmann, Michael M.
    Chinnaiyan, Arul M.
    Putluri, Nagireddy
    Palapattu, Ganesh S.
    Michailidis, George
    Sreekumar, Arun
    NATURE COMMUNICATIONS, 2016, 7